Suchergebnisse - "Li, Lanjuan"

PubPharm (1.326)

21

MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation

enthalten in: Asian journal of pharmaceutical sciences | 2024

von Chen, W. | Lin, F. | Feng, X. | +10

22

Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China : a multicentre, double-blind, phase 3, randomised controlled study

enthalten in: The Lancet. Infectious diseases | 2024

von Fan, X. | Dai, X. | Ling, Y. | +36

23

Effects of partial reduction of polystyrene micro-nanoplastics on the immunity, gut microbiota and metabolome of mice

enthalten in: Chemosphere | 2024

von Zha, H. | Tang, R. | Li, S. | +7

24

Foodborne and airborne polyethersulfone nanoplastics respectively induce liver and lung injury in mice : Comparison with microplastics

enthalten in: Environment international | 2024

von Zha, H. | Xia, J. | Wang, K. | +3

25

CCT3 drives Sorafenib resistance by inhibiting TFRC-mediated iron uptake in HCC

enthalten in: bioRxiv.org | 2023

von Zhu, H. | Liu, Q. | Meng, Q. | +12

26

Non-coding RNA methylation modifications in hepatocellular carcinoma : interactions and potential implications

enthalten in: Cell communication and signaling : CCS | 2023

von Shi, Q. | Chu, Q. | Zeng, Y. | +5

27

Rapid dexamethasone treatment inhibits LPS-induced cytokine storm in mice

enthalten in: bioRxiv.org | 2023

von Zhang, F. | Xiao, L. | Li, Y. | +8

28

Application of hsa-miR7977 in preparation of products for treating autoimmune diseases

enthalten in: Europäisches Patentamt | 2023

von CAO HONGCUI | CHEN WENYI | LI LANJUAN | +3

29

Application of hsa-miR7977 in preparation of products for treating autoimmune diseases

enthalten in: Europäisches Patentamt | 2023

von CAO HONGCUI | CHEN WENYI | LI LANJUAN | +3

30

The influence of microbiota on ferroptosis in intestinal diseases

enthalten in: Gut microbes | 2023

von Yao, T. | Li, L.